BioSpace News Archive

Multiple displacement amplification is a commonly used technique for amplification of DNA that can amplify DNA from a sample having a trace amount of DNA.

Scalpel, also known as lancet, is an instrument with an extremely sharp blade which can be employed for various procedures.

Recombinase Polymerase Amplification is a new isothermal method to amplify the DNA as well as RNA. Recombinase polymerase amplification is simple isothermal reaction technique having fast reaction time and also known for its accuracy.

Various studies conducted recently contend that rehabilitation treatments and therapeutic devices offered at home settings are equally effective as compared to hospitals for a number of surgeries.

AgomAb Therapeutics N.V. announced the closing of a $74 million Series B financing round led by Redmile Group, with participation from Cormorant Asset Management.

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, announced that Dr Megan Baldwin, CEO of Opthea, will virtually present and provide a corporate update at the Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021 at 3:50pm ET.

On the eve of the one-year declaration of the COVID-19 global pandemic, a new survey by the Canadian Medical Association shows high levels of anxiety and fatigue among physicians.

Agena Bioscience®, the global manufacturer of the MassARRAY® System for targeted genetic analysis, announced an exclusive distribution agreement with Alliance Global, the AGBL Group of companies, to bring the MassARRAY technology to many emerging markets across the Middle East, Africa, and Central Asia.

Trueblue, a leading provider of AI solutions for Operational and Analytical CRM in the Life Science industry announces that Angelini Pharma, as part of a major global digital transformation process, has chosen AiDEA, the first AI-Digital Cloud Pharma CRM solution based on Microsoft Dynamics 365.

HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today that it has won a complete dismissal in the federal US securities class action pending in the United States District Court for the Southern District of New York